Medical Ventures Corp.
TSX VENTURE : MEV

Medical Ventures Corp.

June 06, 2007 14:14 ET

Medical Ventures' Invitation to Teleconference Call: Annual Company Update

Tuesday, June 12, 2007-11 a.m. Pacific Time; 2 p.m. Eastern Time

RICHMOND, BRITISH COLUMBIA--(Marketwire - June 6, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV), a medical device company specializing in the development and commercialization of vascular and surgical products, will be holding its annual company update teleconference call on Tuesday, June 12, 2007, at 11 a.m. PDT (2 p.m. EDT). The update will include the Company's financial results for the first quarter of 2007.

Your hosts will be Caren Holtby, investor relations manager, and Paul Geyer, president and CEO. To participate, listeners are asked to dial 604-678-8083 and request the "Medical Ventures teleconference".

A playback will be available from June 12, at 2 p.m. PDT, until midnight on June 26, 2007. To access the playback, listeners should dial 416-695-5800 and quote reference number 3224510. Following the playback, the call will be available on Medical Ventures' website: www.medical-ventures.com.

About Medical Ventures Corp.:

Medical Ventures Corp. is a medical device company dedicated to developing products that address clinical needs in the quickly growing vascular and surgical marketplace. MEV products help doctors treat a wide range of health concerns, including vascular disease and obesity. The Company develops and manufactures the patented Metricath® System vascular measurement technology and PeriPatch™, a range of surgical tissue products. Medical Ventures is also an OEM product manufacturer and materials supplier. For more information please visit www.medical-ventures.com.

Statements contained herein that are not based on historical or current fact, including without limitation statements containing the words "anticipates", "believes", "may", "continues", "estimates", "expects", and "will" and words of similar import, constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, among others, the following: general economic and business conditions, both nationally and in the regions in which the Company operates; technology changes; competition; changes in business strategy or development plans; the ability to attract and retain qualified personnel; existing governmental regulations and changes in, or the failure to comply with, governmental regulations; liability and other claims asserted against the Company; and other factors referenced in the Company's filings with Canadian securities regulators. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company does not assume the obligation to update any forward-looking statements.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information